文献速递焦虑、强迫与应激相关障碍儿童青少年精神

高剂量昂丹司琼对强迫症与抽动障碍临床症状及脑连接影响的随机对照试验

Randomized Controlled Trial of the Effects of High-Dose Ondansetron on Clinical Symptoms and Brain Connectivity in Obsessive-Compulsive and Tic Disorders.
PubMed 文献 · Am J Psychiatry · 2025-01-29

该随机对照试验纳入51名强迫症和/或抽动障碍参与者,比较4周高剂量昂丹司琼(24 mg/天,n=27)与安慰剂(n=24)对感觉现象严重程度及脑连接的影响。全样本中两组在感觉现象或整体强迫症严重程度改善上无显著差异;在合并使用5-羟色胺再摄取抑制剂的强迫症亚组中,昂丹司琼较安慰剂显著降低整体强迫症严重程度及内侧感觉运动皮层全局连接。

要点

  • 全样本中昂丹司琼与安慰剂在感觉现象和整体强迫症严重程度改善上无显著差异。
  • 合并使用5-羟色胺再摄取抑制剂的强迫症亚组中,昂丹司琼较安慰剂显著降低整体强迫症严重程度。
  • 感觉现象严重程度下降与右侧感觉运动枢纽性降低相关,仅在昂丹司琼组与脑干局部一致性相关。

核心结论

  • 高剂量昂丹司琼对感觉现象无显著效果,但作为5-羟色胺再摄取抑制剂的增效治疗时可降低整体强迫症严重程度,这可能与感觉运动皮层枢纽性变化有关。
  • 昂丹司琼调节脑干连接的能力可能解释其在减少感觉现象方面效果不一。

研究设计与样本

  • 随机对照试验采用实验医学方法,51名完成研究的强迫症和/或抽动障碍参与者中27名分配至昂丹司琼24 mg/天组、24名分配至安慰剂组,治疗4周。
  • 分析比较基线至最终访视的感觉现象严重程度变化,强迫症参与者另分析整体强迫症严重程度变化;两次访视均采集功能磁共振数据以分析全局相关(反映脑区枢纽性)和局部相关(反映近邻一致性)的内在功能连接指标。

主要发现

  • 全样本中昂丹司琼组与安慰剂组在感觉现象或整体强迫症严重程度降低上无显著差异。
  • 在合并使用5-羟色胺再摄取抑制剂的强迫症亚组中,昂丹司琼组较安慰剂组整体强迫症严重程度显著降低,内侧感觉运动皮层全局连接显著降低。
  • 两组中感觉现象严重程度的纵向降低均与右侧感觉运动枢纽性降低相关,仅昂丹司琼组与脑干局部一致性相关。

关键数值与推荐

  • 昂丹司琼剂量为24 mg/天,疗程4周。
  • 全样本中昂丹司琼组与安慰剂组在感觉现象或整体强迫症严重程度降低上无显著差异。
  • 合并使用5-羟色胺再摄取抑制剂的强迫症亚组中,昂丹司琼组较安慰剂组整体强迫症严重程度显著降低,内侧感觉运动皮层全局连接显著降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sensory phenomena (SP) are aversive sensations driving repetitive behaviors in obsessive-compulsive disorder (OCD) and Tourette's disorder that are not well addressed by standard treatments. SP are related to the functioning of an interoceptive-sensorimotor circuit that may be modulated by the 5-HT3 receptor antagonist ondansetron. The present study employed an experimental medicine approach to test the effects of 4 weeks of high-dose ondansetron compared to placebo on SP severity and brain connectivity in a cohort of individuals with OCD and/or Tourette's disorder. METHODS: Of 51 participants who completed the study, 27 were assigned to receive 24 mg/day of ondansetron and 24 to receive placebo. Analyses examined changes in SP severity and, for participants with OCD, overall OCD severity from baseline to final visit. Functional MRI data were collected at both visits for analysis of intrinsic functional connectivity metrics characterizing global correlation (reflecting area "hubness") and local correlation (reflecting near-neighbor coherence). RESULTS: There were no significant differences between ondansetron and placebo in the reduction of SP or overall OCD severity in the full sample. In a subsample of participants with OCD taking concomitant serotonin reuptake inhibitors (SRIs), ondansetron was associated with a significant decrease in overall OCD severity and global connectivity of the medial sensorimotor cortex compared with placebo. Longitudinal reductions in SP severity were related to decreases in right sensorimotor hubness in both groups, and to brainstem local coherence only in participants taking ondansetron. CONCLUSIONS: There was no effect of high-dose ondansetron on SP. However, when used as an augmentation to SRIs, ondansetron reduced overall OCD severity, which may be related to changes in the "hubness" of the sensorimotor cortex. Ondansetron's ability to modulate brainstem connectivity may underlie its variable effectiveness in reducing SP.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Stern ER, Collins KA, Bragdon LB, et al. Randomized Controlled Trial of the Effects of High-Dose Ondansetron on Clinical Symptoms and Brain Connectivity in Obsessive-Compulsive and Tic Disorders. Am J Psychiatry. 2025. PMID: 39876680. doi:10.1176/appi.ajp.20240294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。